-
article
Bemmo A, Fortin É and Fortin P, Doggui R, Guay CA, Amini R, Carazo S, Papenburg J, Gilca R
Impact of the first nirsevimab immunization campaign on infant RSV-related emergency department visits and hospitalizations in Québec, Canada
Epidemiology
2026.
-
article
Carazo S, Ouakki M, Skowronski DM, Paquette M, Brousseau N, Talbot D, Guay CA, Quach C, Gilca R, Papenburg J
Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada
Lancet Reg Health Am
57 2026.
-
rapport
Gilca R, Guay CA, Doggui R
Place du vaccin recombinant dans le Programme dimmunisation contre linfluenza: avis scientifique
Institut national de santé publique du Québec, Montréal Québec, p. 2025, ISBN: 9782555013766, .
